Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Endeavour Silver Corp.

Start price
Target price
Perf. (%)
€3.65
23.01.22
-
23.01.23
-16.23%
05.02.22

buy
First Majestic Silver Corp.

Start price
Target price
Perf. (%)
€9.65
23.01.22
-
23.01.23
-9.31%
05.02.22

buy
Hecla Mining Corp.

Start price
Target price
Perf. (%)
€4.68
23.01.22
-
23.01.23
-6.93%
05.02.22

buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€2.46
23.01.22
-
23.01.23
6.50%
06.02.22

buy
Affimed N.V.

Start price
Target price
Perf. (%)
€3.55
23.01.22
-
23.01.23
0.17%
06.02.22

buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€21.95
23.01.22
-
23.01.23
197.04%
24.01.23

buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€3.32
23.01.22
-
23.01.23
-7.83%
06.02.22

Risky Investment
buy
Provention Bio Inc

Start price
Target price
Perf. (%)
€3.24
23.01.22
-
23.01.23
144.81%
24.01.23

buy
Loopring

Start price
Target price
Perf. (%)
€0.71
23.01.22
-
23.01.23
16.11%
17.04.22

buy
Ms Industrie AG

Start price
Target price
Perf. (%)
€1.69
23.01.22
-
23.01.23
-2.37%
05.02.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Future proof or reliable business model
Higher risks for its business
buy
Gateway Real Estate AG

Start price
Target price
Perf. (%)
€3.56
23.01.22
-
23.01.23
23.88%
05.02.22

Innovative
Medium risks for its business
Known brand
buy
NeXR Technologies SE

Start price
Target price
Perf. (%)
€2.00
23.01.22
-
23.01.23
-4.75%
05.02.22

Business model of the past or high risk
Little known brand
Significant cyclical dependencies
Below average Marketposition
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€2.76
23.01.22
-
23.01.23
-8.12%
06.02.22

Risky Investment
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€14.52
23.01.22
-
23.01.23
7.06%
06.02.22

Could be worthwhile Investment >10% per year
buy
Leap Therapeutics Inc.

Start price
Target price
Perf. (%)
€18.46
23.01.22
-
23.01.23
-1.73%
06.02.22

Could be worthwhile Investment >10% per year
buy
Myovant Sciences Ltd

Start price
Target price
Perf. (%)
€12.00
23.01.22
-
23.01.23
-6.50%
06.02.22

Could be very worthwhile Investment >20% year
buy
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€5.05
23.01.22
-
23.01.23
-3.76%
06.02.22

Risky Investment
buy
Geron Corp.

Start price
Target price
Perf. (%)
€0.89
23.01.22
€5.00
23.01.24
129.79%
17.09.23

Very Future proof/growth oriented business model
Strong uniques
Could be very worthwhile Investment >20% year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.30
23.01.22
-
23.01.23
15.82%
06.02.22

Risky Investment
buy
Valneva SE

Start price
Target price
Perf. (%)
€15.90
23.01.22
-
23.01.23
-5.47%
06.02.22

Could be very worthwhile Investment >20% year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€74.55
23.01.22
-
23.01.23
7.12%
06.02.22

Could be very worthwhile Investment >20% year
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€131.05
23.01.22
-
23.01.23
19.38%
06.02.22

Could be very worthwhile Investment >20% year
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€137.00
23.01.22
-
23.01.23
4.37%
06.02.22

Could be very worthwhile Investment >20% year
buy
TCR2 Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.92
23.01.22
-
23.01.23
-7.53%
06.02.22

Risky Investment
buy
Infinity Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.04
23.01.22
-
23.01.23
3.85%
06.02.22